ZFIN ID: ZDB-FISH-200401-1
Fish name: tp53zdf1/zdf1; nn1002Tg; nn1004Tg
Genotype: tp53zdf1/zdf1; nn1002Tg; nn1004Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by tp53zdf1/zdf1; nn1002Tg; nn1004Tg
Human Disease Conditions Citations
hepatocellular carcinoma control Lin et al., 2019
GENE EXPRESSION
Gene expression in tp53zdf1/zdf1; nn1002Tg; nn1004Tg
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in tp53zdf1/zdf1; nn1002Tg; nn1004Tg
Phenotype Conditions Figures
liver ccne1 expression amount, ameliorated chemical treatment by gavage: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, increased food availability Fig. 7 with image from Lin et al., 2019
liver cdk1 expression amount, ameliorated chemical treatment by gavage: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, increased food availability Fig. 7 with image from Lin et al., 2019
liver cdk2 expression amount, ameliorated chemical treatment by gavage: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, increased food availability Fig. 7 with image from Lin et al., 2019
liver dysplastic, exacerbated increased food availability Fig. 7 with image from Lin et al., 2019
liver hyperplastic, exacerbated increased food availability Fig. 7 with image from Lin et al., 2019
liver cdk1 expression increased amount, abnormal increased food availability Fig. 7 with image from Lin et al., 2019
liver ccne1 expression increased amount, abnormal increased food availability Fig. 7 with image from Lin et al., 2019
liver cdk2 expression increased amount, abnormal increased food availability Fig. 7 with image from Lin et al., 2019
liver structure, ameliorated chemical treatment by gavage: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, increased food availability Fig. 7 with image from Lin et al., 2019
liver cell population proliferation increased occurrence, abnormal increased food availability Fig. 7 with image from Lin et al., 2019
liver cell population proliferation occurrence, ameliorated chemical treatment by gavage: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, increased food availability Fig. 7 with image from Lin et al., 2019
liver hepatocellular carcinoma amount, ameliorated chemical treatment by gavage: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, increased food availability Fig. 7 with image from Lin et al., 2019
liver hepatocellular carcinoma increased amount, exacerbated increased food availability Fig. 7 with image from Lin et al., 2019
liver lipid amount, ameliorated chemical treatment by gavage: EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, increased food availability Fig. 7 with image from Lin et al., 2019
liver lipid increased amount, exacerbated increased food availability Fig. 7 with image from Lin et al., 2019

CITATIONS  (1)